Alliance Pharmaceutical Corp. Announces Response to Shareholder Lawsuit.Business Editors SAN DIEGO--(BUSINESS WIRE)--Feb. 28, 2001 Alliance Pharmaceutical Corp. (Nasdaq:ALLP ALLP Aldo Leopold Leadership Program ) announced today that it intends to defend itself vigorously against the claims alleged in a lawsuit filed by two former shareholders of Molecular Biosystems Inc. (MBI MBI Management Buy-In MBI Moody Bible Institute MBI Mathematical Biosciences Institute MBI Modular Building Institute MBI Mechanical Breakdown Insurance MBI Molecular Biology Institute MBI Maslach Burnout Inventory (psychometrics) ) purportedly on behalf of themselves and others against Alliance and certain of its officers. The lawsuit, filed in the U.S. District Court for the Southern District of New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of , alleges violations of certain Federal securities laws in connection with Alliance's acquisition of MBI. The plaintiffs are seeking rescission or compensatory damages A sum of money awarded in a civil action by a court to indemnify a person for the particular loss, detriment, or injury suffered as a result of the unlawful conduct of another. , payment of fees and expenses, and further relief. Alliance believes that the lawsuit, which has not yet been served upon the company, is completely without merit. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion